WHO suggests synthetic antibody treatment for high-risk Covid patients

WHO has recommended Regeneron for Covid-19, but only in patients with specific health profiles.The Regeneron cocktail of synthetic antibodies -- casirivimab and imdevimab -- has been found to reduce the risk of hospitalisation for unvaccinated, elderly or immunosuppressed patients with Covid

from mint - News https://ift.tt/3i1BtcN
https://ift.tt/eA8V8J